Karen L. Zaderej - Jun 20, 2023 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Jun 20, 2023
Transactions value $
$0
Form type
4
Date filed
6/22/2023, 09:18 AM
Previous filing
Mar 20, 2023
Next filing
Jul 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Option (Right to Buy) Award $0 +26.1K $0.00 26.1K Jun 20, 2023 Common Stock 26.1K $3.26 Direct
transaction EYPT Stock Option (Right to Buy) Award $0 +13K $0.00 13K Jun 20, 2023 Common Stock 13K $3.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.